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Abstract
An enantioselective total synthesis of (−)-mucocin has been completed. A combination of
asymmetric glycolate aldol additions and ring closing metathesis reactions were exploited to
construct the C18-C34 and C7-C17 fragments. A selective cross metathesis reaction was employed
as the key step to couple two complex fragments.
In 1995 mucocin (1), a novel member of the anonnaceous acetogenin family, was isolated from
the leaves of Rollinia mucosa by McLaughlin and coworkers.1 The annonaceous acetogenins
are a series of polyethers with antimitotic and cytotoxic properties, containing either adjacent
or nonadjacent tetrahydrofuran (THF) rings. Mucocin was the first member of this family
reported to bear a tetrahydropyran (THP) ring along with a THF ring.2 Mucocin is quite active
in the brine shrimp toxicity (BST) assay (IC50 1.3 μg/mL), and shows remarkably selective
inhibitory effects against A-549 (lung cancer) and PACA-2 (pancreatic cancer) tumor cell lines
with potency 10,000 times that of the known antitumor agent adriamycin.3 Mucocin’s mode
of action is believed to result from inhibition of both the mitochondrial complex I (NADH-
ubiquinone oxidoreductase) and the plasma membrane NADH oxidase. Consequently, the ATP
level of the tumor cells decreases and apoptosis is induced.4 The potent antitumor activity and
the unique structure of mucocin have stimulated numerous synthetic endeavors; five previous
total syntheses of mucocin have published.5
Herein we describe an enantioselective total synthesis of (−)-mucocin. Mucocin was
envisioned to derive from the coupling of advanced acetylene 2 and known butenolide 36 via
a Pd(0) catalyzed Sonogashira reaction (Scheme 1). The bis cyclic ether 2 would be generated
by coupling fragments 4 and 5 through a cross metathesis reaction, wherein both fragments
would be prepared via an asymmetric glycolate aldol-ring closing metathesis (RCM) sequence.
The synthesis of the C18-C34 fragment 4 started with the protection of the known compound
(2R,3R)-1-oxiranyl-undecan-1-ol (6)7 as its THP ether, followed by epoxide opening8 to afford
the homologated allylic alcohol 7 in 87% yield (Scheme 2). The resulting secondary alcohol
was protected as a benzyl ether, and the THP group was removed under acidic conditions to
deliver alcohol 8 in 86% yield over the two steps. Alkylation of the sodium alkoxide of alcohol
8 with sodium bromoacetate gave a glycolic acid, which was converted to its mixed pivalic
anhydride and treated with (R)-3-lithio-4-benzyl-2-oxazolidinone to generate the N -
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protocol9 was then exploited, where the chlorotitanium enolate of glycolate 9 was formed by
treatment with TiCl4 (1.0 equiv), i-Pr2NEt (2.5 equiv) and N-methyl-2-pyrrolidinone (1.0
equiv). Addition of acrolein to the enolate solution gave the desired syn aldol adduct 10 in good
yield and diastereoselectivity (77%, 11:1 dr). Other aldol protocols gave significantly lower
yields and diastereoselectivity. Protection of the resulting alcohol 10 as its TES ether and
reductive removal of the chiral auxiliary afforded primary alcohol 11 in 93% yield. The
subsequent Swern oxidation10-Wittig reaction sequence delivered triene 12 in 83% yield.
Triene 12 was exposed to the Grubbs second generation catalyst11 [Cl2(PCy3)(IMes)
Ru=CHPh], followed by acidic workup to remove the TES protecting group in the same pot,
regioselectively generating dihydropyran 4 in good yield.12 The use of the triethylsilyl ether
as the alcohol protecting group in triene 12 resulted in less than 5% of the corresponding seven
membered ring metathesis product.
Preparation of the C7-C17 fragment 5 began by protecting the terminal alkyne of 5-hexyn-1-
ol (13) with a TIPS group (Scheme 4).13 Swern oxidation of the resultant primary alcohol and
a subsequent Grignard reaction with vinylmagnesium bromide delivered allylic alcohol 14 in
66% yield over three steps. Allylic alcohol 14 was then exposed to the standard Sharpless
kinetic resolution conditions14 [(+)-dicyclohexyl tartrate (DCHT), Ti(i-PrO)4, t-BuOOH, 4Å
molecular sieves]. The reaction was quenched at 52% conversion to provide alcohol 15 in 92%
ee.15 Alkylation of the secondary alcohol with sodium bromoacetate and coupling of the
resultant acid to (R)-3-lithio-4-benzyl-2-oxazolidinone gave glycolate 1 6 in 77% yield. Once
again, the NMP-promoted asymmetric aldol reaction was utilized. Exposure of glycolate 16 to
these conditions with acrolein provided the aldol adducts in 82% yield (93% based on recovered
starting material), with a 4:1 dr favoring the desired s y n adduct 17. Silylation of the mixture
of diastereomers as TES ethers and reductive removal of the auxiliary afforded the primary
alcohol 18 in 89% yield.
With the desired stereocenters established, efforts focused on the regioselective formation of
the five-membered ring. Previous studies from our laboratory showed that the RCM reaction
of simple triene 19 with the ruthenium alkylidene catalysts gave a poor regioselectivity of five-
membered and six-membered cyclic ethers (Scheme 3).16 We rationalized that the unexpected
result was due to indiscriminate insertion of the ruthenium carbene into all three alkenes of
triene 19, followed by fast ring closure to generate both regioisomers. To circumvent this
problem, Hoye’s “activation” strategy was utilized, where the RCM substrate 20 was modified
to contain an allyloxymethyl side chain.17 In this case, the ruthenium carbene complex
preferentially inserts in the terminal alkene of the allyloxymethyl group for both steric and
electronic reasons, generating 2,5-dihydrofuran as a byproduct and leaving the metal carbene
in the desired position to construct the five-membered cyclic ether selectively.
This successful strategy was applied to the synthesis of fragment 5 (Scheme 4). Alcohol 1 8
was subjected to Swern oxidation, followed by Wittig olefination with Ph3P=CHCO2Me in
the same pot (no evidence of epimezaion of the aldehyde was detected). The resultant α, β-
unsaturated ester 21 underwent selective 1,2-reduction with i-Bu2AlH, whereupon the primary
alcohol was O-alkylated with allyl bromide to deliver tetraene 22 in excellent yield. Exposure
of tetraene 22 to the Grubbs second generation catalyst provided excellent regioselectivity,
giving a 7:1 ratio of the five- and six-membered rings. After removal of the TES group with
acidic workup of the RCM reaction, cyclic ether 23 was isolated in 87% yield. No byproduct
from any metathesis reaction of the acetylene was identified. The alcohol 2 3 was then
converted to its MOM ether 5 in 89% yield.
With fragments 4 and 5 in hand, the key cross metathesis reaction was undertaken (Scheme
4). The disubstituted internal olefin of each fragment was expected to be unreactive under cross
metathesis conditions, allowing for chemoselective reactions between the remaining two
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terminal vinyl groups of these compounds. The MOM protecting group on fragment 5 was
anticipated to modify the steric accessibility of the nearby allylic olefin, making it less reactive
than the structrually similar unprotected allylic olefin on fragment 4. The difference in
reactivities of the two alkenes would lead to a selective cross metathesis reaction.18 Exposure
of a 1:1 mixture of alkenes 4 and 5 to the Hoveyda-Grubbs second generation catalyst
[Cl2(IMes)Ru=CH-o-Oi-PrC6H4], 19 yielded the desired cross coupling product 24 in 68%
yield (6:1 E:Z by HPLC), along with 13% of alkene 5 recovered and 23% of the homodimer
of 4.20 Using the Grubbs second generation catalyst gave a lower yield of 53% under similar
reaction conditions. Mooto recently reported a similar cross-metathesis approach to
mucocin5e as well as other acetogenins,21 but utilizing different allylic alcohol protecting
groups. The terminal TIPS group was then readily removed. The resultant alkyne 2 was coupled
with known vinyl iodide 36 under Sonogashira coupling conditions [Pd(PPh3)2Cl2, CuI,
NEt3]22 to provide polyenyne 25. The use of Pd(PPh3)2Cl2 as a precatalyst proved superior
to Pd(PPh3)4 (82% vs 50% yield). Selective hydrogenation of the pentaenyne moiety with
diimide generated in situ from tosylhydrazide23 afforded butenolide 26 in 77% yield. The total
synthesis of (−)-mucocin was completed by removal of the protecting groups with BF3·OEt2
and Me2S. 6 Synthetic 1 was identical in all aspects (1H, 13C, MS, [α]24 D) to the natural
product.5
In summary, the enantioselective total synthesis of (−)-mucocin has been accomplished in 19
linear steps from commerically available 5-hexyn-1-ol. This approach highlights a combination
of asymmetric glycolate aldol additions and RCM metatheses to construct the cyclic ethers. In
addition, Hoye’s “activation” strategy was applied to the regioselective formation of a
dihydrofuran. The synthesis also employed a selective cross metathesis reaction for the
coupling of two complex alkene fragments.
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